{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:59:21Z","timestamp":1783717161269,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Region of Southern Denmark"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00223-019-00526-z","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T13:28:55Z","timestamp":1549027735000},"page":"591-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Elevated Bone Remodeling Markers of CTX and P1NP in Addition to Sclerostin in Patients with X-linked Hypophosphatemia: A Cross-Sectional Controlled Study"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-0316","authenticated-orcid":false,"given":"Stinus","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-2808","authenticated-orcid":false,"given":"Vikram V.","family":"Shanbhogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-5210","authenticated-orcid":false,"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-9217","authenticated-orcid":false,"given":"Signe Sparre","family":"Beck-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"526_CR1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(03)14636-3","volume":"362","author":"B Wharton","year":"2003","unstructured":"Wharton B, Bishop N (2003) Rickets. Lancet 362:1389\u20131400","journal-title":"Lancet"},{"key":"526_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000072774","volume":"6","author":"MK Drezner","year":"2003","unstructured":"Drezner MK (2003) Hypophosphatemic rickets. Endocr Dev 6:126\u2013155","journal-title":"Endocr Dev"},{"key":"526_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","volume":"87","author":"SS Beck-Nielsen","year":"2010","unstructured":"Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, Poulsen MR, Vestergaard P, Ralston SH, Albagha OM, Poulsen S, Haubek D, Gjorup H, Hintze H, Andersen MG, Heickendorff L, Hjelmborg J, Gram J (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108\u2013119","journal-title":"Calcif Tissue Int"},{"key":"526_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0221-8747(82)90035-2","volume":"4","author":"PJ Marie","year":"1982","unstructured":"Marie PJ, Glorieux FH (1982) Bone histomorphometry in asymptomatic adults with hereditary hypophosphatemic vitamin D-resistant osteomalacia. Metab Bone Dis Relat Res 4:249\u2013253","journal-title":"Metab Bone Dis Relat Res"},{"key":"526_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0221-8747(81)80020-3","volume":"3","author":"PJ Marie","year":"1981","unstructured":"Marie PJ, Glorieux FH (1981) Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets. Metab Bone Dis Relat Res 3:31\u201338","journal-title":"Metab Bone Dis Relat Res"},{"key":"526_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0002-9343(91)90507-T","volume":"90","author":"IR Reid","year":"1991","unstructured":"Reid IR, Murphy WA, Hardy DC, Teitelbaum SL, Bergfeld MA, Whyte MP (1991) X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry. Am J Med 90:63\u201369","journal-title":"Am J Med"},{"key":"526_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","volume":"303","author":"FH Glorieux","year":"1980","unstructured":"Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023\u20131031","journal-title":"N Engl J Med"},{"key":"526_CR8","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","volume":"325","author":"CF Verge","year":"1991","unstructured":"Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843\u20131848","journal-title":"N Engl J Med"},{"key":"526_CR9","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1210\/jc.2003-030036","volume":"88","author":"O Makitie","year":"2003","unstructured":"Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591\u20133597","journal-title":"J Clin Endocrinol Metab"},{"key":"526_CR10","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1210\/jc.2015-2957","volume":"100","author":"P Chavassieux","year":"2015","unstructured":"Chavassieux P, Portero-Muzy N, Roux JP, Garnero P, Chapurlat R (2015) Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women? J Clin Endocrinol Metab 100:4662\u20134668","journal-title":"J Clin Endocrinol Metab"},{"key":"526_CR11","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2106\/JBJS.M.01096","volume":"96","author":"JT Compton","year":"2014","unstructured":"Compton JT, Lee FY (2014) A review of osteocyte function and the emerging importance of sclerostin. J Bone Joint Surg Am 96:1659\u20131668","journal-title":"J Bone Joint Surg Am"},{"key":"526_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00223-017-0363-3","volume":"102","author":"VV Shanbhogue","year":"2018","unstructured":"Shanbhogue VV, Hansen S, Jorgensen NR, Beck-Nielsen SS (2018) Impact of conventional medical therapy on bone mineral density and bone turnover in adult patients with X-linked hypophosphatemia: a 6-year prospective cohort study. Calcif Tissue Int 102:321\u2013328","journal-title":"Calcif Tissue Int"},{"key":"526_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jbmr.2310","volume":"30","author":"VV Shanbhogue","year":"2015","unstructured":"Shanbhogue VV, Hansen S, Folkestad L, Brixen K, Beck-Nielsen SS (2015) Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets. J Bone Miner Res 30:176\u2013183","journal-title":"J Bone Miner Res"},{"key":"526_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/jhg.2012.56","volume":"57","author":"SS Beck-Nielsen","year":"2012","unstructured":"Beck-Nielsen SS, Brixen K, Gram J, Brusgaard K (2012) Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet 57:453\u2013458","journal-title":"J Hum Genet"},{"key":"526_CR15","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/jbmr.2817","volume":"31","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue VV, Brixen K, Hansen S (2016) Age- and sex-related changes in bone microarchitecture and estimated strength: a three-year prospective study using HRpQCT. J Bone Miner Res 31:1541\u20131549","journal-title":"J Bone Miner Res"},{"key":"526_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12020-011-9512-z","volume":"40","author":"Y Nagata","year":"2011","unstructured":"Nagata Y, Imanishi Y, Ishii A, Kurajoh M, Motoyama K, Morioka T, Naka H, Mori K, Miki T, Emoto M, Inaba M (2011) Evaluation of bone markers in hypophosphatemic rickets\/osteomalacia. Endocrine 40:315\u2013317","journal-title":"Endocrine"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00774-004-0594-z","volume":"23","author":"I Ros","year":"2005","unstructured":"Ros I, Alvarez L, Guanabens N, Peris P, Monegal A, Vazquez I, Cerda D, Ballesta AM, Munoz-Gomez J (2005) Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J Bone Miner Metab 23:266\u2013269","journal-title":"J Bone Miner Metab"},{"key":"526_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jcph.570","volume":"56","author":"X Zhang","year":"2016","unstructured":"Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Carpenter TO, Peacock M (2016) Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia. J Clin Pharmacol 56:176\u2013185","journal-title":"J Clin Pharmacol"},{"key":"526_CR19","doi-asserted-by":"crossref","unstructured":"McKenna MJ, Martin-Grace J, Crowley R, Twomey PJ, Kilbane MT (2018) Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy. J Bone Miner Metab Sep 20 Epub ahead of print:","DOI":"10.1007\/s00774-018-0957-5"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000223688","volume":"16","author":"F Rauch","year":"2009","unstructured":"Rauch F (2009) Bone biopsy: indications and methods. Endocr Dev 16:49\u201357","journal-title":"Endocr Dev"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","volume":"93","author":"JL Millan","year":"2013","unstructured":"Millan JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93:299\u2013306","journal-title":"Calcif Tissue Int"},{"key":"526_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11914-014-0223-2","volume":"12","author":"KE White","year":"2014","unstructured":"White KE, Hum JM, Econs MJ (2014) Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis. Curr Osteoporos Rep 12:252\u2013262","journal-title":"Curr Osteoporos Rep"},{"key":"526_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jbmr.110","volume":"25","author":"WN Addison","year":"2010","unstructured":"Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25:695\u2013705","journal-title":"J Bone Miner Res"},{"key":"526_CR24","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.1.05989","volume":"183","author":"D Bresler","year":"2004","unstructured":"Bresler D, Bruder J, Mohnike K, Fraser WD, Rowe PS (2004) Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets. J Endocrinol 183:R1\u2013R9","journal-title":"J Endocrinol"},{"key":"526_CR25","doi-asserted-by":"publisher","first-page":"E920","DOI":"10.1210\/jc.2013-3852","volume":"99","author":"T Palomo","year":"2014","unstructured":"Palomo T, Glorieux FH, Rauch F (2014) Circulating sclerostin in children and young adults with heritable bone disorders. J Clin Endocrinol Metab 99:E920\u2013E925","journal-title":"J Clin Endocrinol Metab"},{"key":"526_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bone.2014.11.011","volume":"72","author":"LV Zelenchuk","year":"2015","unstructured":"Zelenchuk LV, Hedge AM, Rowe PS (2015) SPR4-peptide alters bone metabolism of normal and HYP mice. Bone 72:23\u201333","journal-title":"Bone"},{"key":"526_CR27","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/jbmr.345","volume":"26","author":"GJ Atkins","year":"2011","unstructured":"Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR, Zelenchuk L, Evdokiou A, Findlay DM (2011) Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 26:1425\u20131436","journal-title":"J Bone Miner Res"},{"key":"526_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jsbmb.2014.11.021","volume":"148","author":"ZC Ryan","year":"2015","unstructured":"Ryan ZC, Craig TA, McGee-Lawrence M, Westendorf JJ, Kumar R (2015) Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass. J Steroid Biochem Mol Biol 148:225\u2013231","journal-title":"J Steroid Biochem Mol Biol"},{"key":"526_CR29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ar.a.10119","volume":"275","author":"HM Frost","year":"2003","unstructured":"Frost HM (2003) Bone\u2019s mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 275:1081\u20131101","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"526_CR30","doi-asserted-by":"publisher","first-page":"E990","DOI":"10.1210\/jc.2012-4146","volume":"98","author":"LN Veilleux","year":"2013","unstructured":"Veilleux LN, Cheung MS, Glorieux FH, Rauch F (2013) The muscle-bone relationship in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 98:E990\u2013E995","journal-title":"J Clin Endocrinol Metab"},{"key":"526_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.clinbiochem.2012.03.023","volume":"45","author":"MK Koivula","year":"2012","unstructured":"Koivula MK, Risteli L, Risteli J (2012) Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum. Clin Biochem 45:920\u2013927","journal-title":"Clin Biochem"},{"key":"526_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1084\/jem.179.2.405","volume":"179","author":"J Melkko","year":"1994","unstructured":"Melkko J, Hellevik T, Risteli L, Risteli J, Smedsrod B (1994) Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 179:405\u2013412","journal-title":"J Exp Med"},{"key":"526_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0004563213515190","volume":"51","author":"TT Hlaing","year":"2014","unstructured":"Hlaing TT, Compston JE (2014) Biochemical markers of bone turnover\u2014uses and limitations. Ann Clin Biochem 51:189\u2013202","journal-title":"Ann Clin Biochem"},{"key":"526_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1148\/radiology.171.2.2539609","volume":"171","author":"DC Hardy","year":"1989","unstructured":"Hardy DC, Murphy WA, Siegel BA, Reid IR, Whyte MP (1989) X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 171:403\u2013414","journal-title":"Radiology"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00526-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T19:07:30Z","timestamp":1580497650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00526-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Signe Sparre Beck-Nielsen received a payment from Pharmacosmos for participation in an expert meeting and payments from Kyowa Kirin for invited speeches. She also provides consultancy to Strakan International. Stinus Hansen, Vikram V Shanbhogue\u00a0and Niklas Rye J\u00f8rgensen declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study and the Regional Scientific Ethical Committee for Southern Denmark approved the study (reference numbers S-20120155 and S-20090069).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}